Search Results

Baxter Reports Second-Quarter 2025 Results

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025. 

Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2025 financial results on Thursday, July 31, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156238 to pre-register for the call and receive the call information.

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on October 1, 2025, to stockholders of record as of August 29, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter

How A Clinical Nutrition Fellowship is Supporting and Shaping Global Healthcare Leaders

Clinical nutrition is a cornerstone of patient care, supporting patient recovery, growth, and overall health.

Baxter Appoints Andrew Hider Chief Executive Officer

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Mr. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or an earlier date pending completion of his current employment commitments.

Five Steps to Medical Device Connectivity With Purpose

What is the purpose of medical device connectivity? While most healthcare professionals would agree that connectivity is important, it isn’t typically the end goal of a project. More often, the purpose of connectivity lies in supporting a clinical or operational outcome for patients and care teams.

Making the Most of Your Technology Investments

You’ve gone through a thorough evaluation process and chosen a new connected medical device or software solution for your healthcare organization. Now what?

Maximizing the value of your technology investments calls for a multi-faceted approach. From involving the right people to tailoring training programs and beyond, change management starts in a project’s earliest days and extends well beyond go-live.

Big Data in Healthcare: Its Potential to Save Lives

The term “big data” carries plenty of connotations, and they are not all positive. But when we think of its overarching goal in healthcare — harnessing large volumes of data with the goal of supporting better outcomes for patients and care teams — it becomes much more actionable.

Baxter Publishes Annual Corporate Responsibility Report, Demonstrating Ongoing Action to Make a Meaningful Difference Around the World

Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2024 Corporate Responsibility Report.

Taking A Purpose-Driven Approach

As we celebrate the dedication and expertise of our team members, today we're shining a spotlight on Mario Gentileschi, Director, Strategic Portfolio & Market – Western Europe Pharma, who believes we are each the owners of our own development and career success. Mario has spent 17 remarkable years at Baxter and his story is a testament to the power of purpose-driven leadership, collaboration and continuous growth.